HC Q study #40
See all studies
Late treatment study
Chamieh et al., medRxiv 2020.05.28.20114835, doi:10.1101/2020.05.28.20114835 (Preprint)
Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxych loroquine and azithromycin in Lebanon
HC Q+AZ potentially explains 94.7% success in treating a fairly complex cohort.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.